Patent · US Active

Immuno-modulated replication-efficient Vaccinia virus strain

US12295979B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 28, 2023
Grant dateMay 13, 2025
Priority date—
Expiry dateMar 28, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/24143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention refers to new immuno-modulated replication-efficient Vaccinia virus strain (IOVA) and its derivatives for the use in medicine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.